CGRP migraine drugs on every 2026 Virgin Islands Part D plan
Pick a drug class, or type the drugs you want to check, and see which of the 1 stand-alone Part D plans in Virgin Islands cover each one, on what tier, and with what restrictions.
- Covered
- Covered, needs prior authorization (PA) or step therapy (ST)
- Not on the formulary
- QL 60/30d = quantity limit, 60 units per 30 days
| Drug | AARP Medicare Rx Preferred from UHC$114.80/moS5820-038 |
|---|---|
| Aimovigerenumab | Tier 3PA25%QL 1/28d |
| Ajovyfremanezumab | Not covered |
| Emgalitygalcanezumab | Tier 3PA25%QL 2/28d |
| Nurtec ODTrimegepant | Tier 4PA25%QL 18/30d |
| Ubrelvyubrogepant | Tier 4PA25%QL 16/30d |
| Quliptaatogepant | Tier 4PA25%QL 30/30d |
| Zavzpretzavegepant nasal spray | Not covered |
Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.